In an exclusive statement released through Guggenheim Securities, LLC, former Pfizer CEO Ian Read and former CFO Frank D’Amelio addressed growing s...
As President of EMEA at Vision Johnson & Johnson, Jacqueline Henderson is at the forefront of innovation in ophthalmology, overseeing the development...
Results delivered in prestigious Proffered Paper oral presentation at ESMO Congress 2024 In patients with any PD-L1 expression (CPS ≥1), efti in co...
In an interview with BioPharma BoardRoom, Cem Zorlular, CEO of Er-Kim, shares his personal journey and the driving force behind Er-Kim's mission to...
Detailed scientific analysis of antiviral pipeline identifies most promising clinical compounds aligned with 100 Days Mission global preparedness recommend...
Cytiva shines as a model of sustainable principles in the dynamic field of life sciences, where pioneering innovation intersects with societal resp...
In an interview with BioPharma BoardRoom, Eric Blair, GDMC’s Chief Business Officer, discusses the company's strategic use of Series A funding to pio...
From The BioPharma BoardRoom Lens The news of Tomas Blomquist stepping down from his role as CEO & President of Biotage AB carries sev...
As we stand on the precipice of 2024, the life sciences industry continues its dynamic evolution, propelled by groundbreaking discoveries, technological ad...
Cold Spring Harbor Laboratory (CSHL) Professor Christopher Hammell has found that in the worm C. elegans, this genetic orchestra has no single conduct...
More than three in five (63%) people in the UK experience barriers to health inclusion People in UK, Canada and France face the longest waiting times to...
In the world of biotechnology and pharmaceuticals, innovation is the lifeblood of progress. And in the picturesque Basel area, this spirit of innovation is...
In a rapidly evolving world where scientific breakthroughs are essential for the betterment of healthcare, MoleculeAI stands at the forefront, pioneering t...
One in Four American Adults Would Rather Not Know They Have Cancer A new study from The Harris Poll, commissioned by Bayer, suggests fear factors ...
© 2024 Biopharma Boardroom. All Rights Reserved.
